The collagen your body builds after Sculptra treatment becomes part of your own tissue its yours to keep. Addressing "Ozempic Face" and GLP-1 Weight Loss Facial Hollowing The widespread adoption of GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has created one of the most rapidly growing patient concerns in cosmetic dermatology: medication-driven facial volume loss , colloquially known as Ozempic Face. While these medications are remarkably effective for weight management and metabolic health, the rapid fat loss they produce does not discriminate facial fat pads that provide youthful structure to the temples, cheeks, and jawline are depleted alongside body fat, often leaving patients with a hollow, aged appearance that contradicts the healthier physique theyve worked to achieve
One drink turned into three, and three turned into well, lets not talk numbers
Body weight measured at the same time daily, preferably first thing in the morning after using the bathroom
GHRP-6 acts as an agonist at the growth hormone secretagogue receptor 1a (GHS-R1a), which was later identified as the ghrelin receptor after Kojima and colleagues discovered ghrelin as its endogenous ligand in 1999
